The stock of Cutera Inc. (NASDAQ:CUTR) last traded at $20.05, up 9.80% from the previous session.
Data from the available sources indicates that Cutera Inc. (NASDAQ:CUTR) is covered by 6 analysts. The consensus rating among analysts is ‘Hold’. CUTR stock price is now 23.72% away from the 50-day moving average and -33.96% away from the 200-day moving average. The market capitalization of the company currently stands at $363.11M.
In total, 3 analysts have assigned it a hold rating, and 2 have given it a buy rating.
With the price target enhanced from $14 to $18, Piper Sandler Upgraded its rating from Underweight to Neutral for Cutera Inc. (NASDAQ: CUTR).
Insiders disposed of 26,635 shares of company stock worth roughly $0.53 million over the past 1 year. A total of 1.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CUTR stock. A new stake in Cutera Inc. shares was purchased by IRON TRIANGLE PARTNERS LP during the first quarter worth $12,030,000. BOOTHBAY FUND MANAGEMENT, LLC invested $4,855,000 in shares of CUTR during the first quarter. In the first quarter, SIMPLEX TRADING, LLC acquired a new stake in Cutera Inc. valued at approximately $992,000. ATOM INVESTORS LP acquired a new stake in CUTR for approximately $534,000. Y-INTERCEPT (HONG KONG) LTD purchased a new stake in CUTR valued at around $413,000 in the second quarter. In total, there are 201 active investors with 131.60% ownership of the company’s stock.
With an opening price of $18.75 on Friday morning, Cutera Inc. (NASDAQ: CUTR) set off the trading day. During the past 12 months, Cutera Inc. has had a low of $13.21 and a high of $54.04. The fifty day moving average price for CUTR is $16.29 and a two-hundred day moving average price translates $30.23 for the stock.
The latest earnings results from Cutera Inc. (NASDAQ: CUTR) was released for Mar, 2023. According to the Medical Devices Company, earnings per share came in at -$0.8, missing analysts’ expectations of -$0.39 by -0.41. This compares to -$0.84 EPS in the same period last year. The company reported revenue of $54.99 million for the quarter, compared to $58.01 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -5.21 percent. For the current quarter, analysts expect CUTR to generate $64.95M in revenue.
Cutera Inc.(CUTR) Company Profile
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
